Benzinga | Feb 25, 2021 04:25PM EST

Collegium Pharmaceutical Q4 EPS $0.20 Misses $0.29 Estimate, Sales $76.27M Miss $77.41M Estimate

Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $0.20 per share which missed the analyst consensus estimate of $0.29 by 31.03 percent. This is a 385.71 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $76.27 million which missed the analyst consensus estimate of $77.41 million by 1.47 percent. This is a 2.79 percent increase over sales of $74.20 million the same period last year.